Hostname: page-component-84b7d79bbc-dwq4g Total loading time: 0 Render date: 2024-07-25T14:51:39.006Z Has data issue: false hasContentIssue false
  • English
  • Français

Single-Photon Emission Computerised Tomography (Spect) in Schizophrenia

Published online by Cambridge University Press:  02 January 2018

Keith Hawton ,
Basil Shepstone ,
Nigel Soper  and
Lawrie Reznek
Keith Hawton*
Affiliation:
Warneford Hospital and University Department of Psychiatry, Warneford Hospital, Oxford OX3 7JX
Basil Shepstone
Affiliation:
John Radcliffe Hospital and University Department of Radiology, John Radcliffe Hospital, Oxford OX3 9DU
Nigel Soper
Affiliation:
Department of Radiation Physics, Churchill Hospital, Oxford OX3 7LJ
Lawrie Reznek
Affiliation:
Warneford Hospital, Oxford OX3 7JX
*
∗Correspondence
Get access Rights & Permissions [Opens in a new window]

Abstract

SPECT studies were carried out on three occasions in a woman with schizophrenia. Marked ‘hypofrontality’ was demonstrated during an acute phase of illness. A study during remission was within normal limits, but some return of the original defect was noted in a subsequent relapse. These findings parallel those found in PET studies of schizophrenia.

Type
Brief Reports
Information
The British Journal of Psychiatry , Volume 156 , Issue 3 , March 1990 , pp. 425 - 427
Copyright
Copyright © Royal College of Psychiatrists, 1990 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Biersak, H. J., Winkler, C., Reichmann, K., et al (1985) 99mTc-labelled hexamethylpropylene oxime photon emission scans in epilepsy. Lancet, ii, 1436–1437.Google Scholar
Buchsbaum, M. S., Delisi, L. E., Holcomb, H. H., et al (1984) Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorder. Archives of General Psychiatry, 41, 1159–1166.CrossRefGoogle Scholar
Cohen, M. B., Graham, L. S., Lake, R., et al (1986) Diagnosis of Alzheimer's disease and multiple infarct dementia by tomographic imaging of iodine-123 IMP. Journal of Nuclear Medicine, 27, 769–774.Google Scholar
Crawley, J. C. W., Crow, T. J., Johnstone, E. C., et al (1986) Uptake of 77Br-spiperone in the striata of schizophrenic patients and controls. Nuclear Medicine Communications, 7, 599–607.Google Scholar
Delisi, L. E., Holcomb, H. H., Cohen, R. M., et al (1985) Positron emission tomography in schizophrenic patients with and without neuroleptic medication. Journal of Cerebral Blood Flow and Metabolism, 5, 201–206.Google Scholar
Engel, J. Jr, Brown, W. J., Kuhl, D. E., et al (1982) Pathological findings underlying focal temporal lobe hypometabolism in partial epilepsy. Annals of Neurology, 12, 518–528.Google Scholar
Gur, R. E., Resnick, S. M., Alavi, A., et al (1987) Regional brain function in schizophrenia: I. A positron emission tomography study. Archives of General Psychiatry, 44, 119–125.CrossRefGoogle Scholar
Holmann, B. L., Hill, T. C. & Magistretti, P. L. (1982) Brain imaging with emission computed tomography and radiolabelled amines. Investigative Radiology, 17, 206–211.Google Scholar
Kreiten, K., Biersack, H. J., Froescher, W., et al (1985) Erste Erfahrungen mit der “single-photon-emission computed tomography” (SPECT) des Gehirns bei Patienten mit Epilepsie. Akta Neurologica, 12, 8–12.Google Scholar
Leonard, J. P., Nowotnik, D. P. & Neirinckx, R. D. (1986) Technetium-99m-d,I-HM-PAO: a new radiopharmaceutical for imaging regional brain perfusion using SPECT – A comparison with iodine-123 HIPDM. Journal of Nuclear Medicine, 27, 1819–1823.Google Scholar
Magistretti, P. L., Uren, R., Shomer, D., et al (1982) Emission tomographic scans of cerebral blood flow using 1123–iodo-amphetamine in epilepsy. In Nuclear Medicine and Biology, Proceedings of the Third World Congress of Nuclear Medicine and Biology (ed. Raynard, C.), pp. 139–143. Paris: Pergamon Press.Google Scholar
Podreka, I., Suess, E., Goldenberg, G., et al (1987) Initial experience with technetium-99m HM-PAO brain SPECT. Journal of Nuclear Medicine, 28, 1657–1666.Google Scholar
Sharp, P., Gemmell, H., Cherryman, G., et al (1986) Application of iodine-123 labelled isopropylamphetamine imaging to the study of dementia. Journal of Nuclear Medicine, 27, 761–768.Google Scholar
Slater, E., Beard, A. W. & Glitheroe, E. (1963) The schizophrenia-like psychoses of epilepsy. British Journal of Psychiatry, 109, 95–150.Google Scholar
Smith, M. R. & Brodie, J. D. (1986) Positron emission tomographic studies in schizophrenia: a review. In New Brain Imaging Techniques and Psychopharmacology (ed. Trimble, M. R.), pp. 35–48. Oxford: Oxford University Press.Google Scholar
Wagner, H. J. Jr (1986) SPECT and PET advances herald new era in human biochemistry. Journal of Nuclear Medicine, 27, 1227–1232, 1236–1241.Google Scholar
Wolkin, A., Jaeger, J., Brodie, J. D., et al (1985) Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. American Journal of Psychiatry, 142, 564–571.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.